S. Baghrous, “Beyond Current Therapies: In Silico Drug Repurposing as a Strategy to Overcome Tyrosine Kinase Inhibitor Resistance in NSCLC”, J. Drug Delivery Ther., vol. 15, no. 8, pp. 207–216, Aug. 2025, doi: 10.22270/jddt.v15i8.7276.